Paper42226136
Combining preoperative clinical and ultrasound radiomic features to predict the predominant component of combined hepatocellular carcinoma-cholangiocarcinoma.
Yang Y and 9 others. BMC Gastroenterol, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Combining preoperative clinical and ultrasound radiomic features to predict the predominant component of combined hepatocellular carcinoma-cholangiocarcinoma. Papers, record 42226136. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42226136
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Combining preoperative clinical and ultrasound radiomic features to predict the predominant component of combined hepatocellular carcinoma-cholangiocarcinoma.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cholangiocarcinoma | Major topic |
| Carcinoma, Hepatocellular | Major topic |
| Liver Neoplasms | Major topic |
| Bile Duct Neoplasms | Major topic |
| Humans | |
| Radiomics | |
| Ultrasonography | |
| Male | |
| Female | |
| Middle Aged | |
| Aged | |
| Retrospective Studies | |
| Predictive Value of Tests |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 202410598008 | Guangxi Medical University Undergraduate Innovation and Entrepreneurship Training Program | PubMed | ||
| No.YYZS2020024 | the Clinical Research Climbing Project of The First Affiliated Hospital of Guangxi Medical University | PubMed |
Source PubMed
References29
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16613323 | Prognostic impact of cholangiocellular and sarcomatous components in combined hepatocellular and cholangiocarcinoma. | Hum Pathol | 2006 | https://conductscience.org/library/papers/16613323 | PubMed |
| 2 | 31335362 | Combined Hepatocellular Cholangiocarcinoma: A Population-Based Retrospective Study. | Am J Gastroenterol | 2019 | https://conductscience.org/library/papers/31335362 | PubMed |
| 3 | 34234239 | Preoperative nomogram for microvascular invasion prediction based on clinical database in hepatocellular carcinoma. | Sci Rep | 2021 | https://conductscience.org/library/papers/34234239 | PubMed |
| 4 | 32385649 | Combined hepatocellular-cholangiocarcinoma: which preoperative clinical data and conventional MRI characteristics have value for the prediction of microvascular invasion and clinical significance? | Eur Radiol | 2020 | https://conductscience.org/library/papers/32385649 | PubMed |
| 5 | 31512867 | Interpretation of Compound Activity Predictions from Complex Machine Learning Models Using Local Approximations and Shapley Values. | J Med Chem | 2020 | https://conductscience.org/library/papers/31512867 | PubMed |
| 6 | 36112193 | Combined hepatocellular carcinoma-cholangiocarcinoma with a predominant HCC component: better survival and MRI-based prediction. | Eur Radiol | 2023 | https://conductscience.org/library/papers/36112193 | PubMed |
| 7 | 30799097 | Imaging features of combined hepatocellular and cholangiocarcinoma compared with those of hepatocellular carcinoma and intrahepatic cholangiocellular carcinoma in a Chinese population. | Clin Radiol | 2019 | https://conductscience.org/library/papers/30799097 | PubMed |
| 8 | 29667093 | The Predictive Value of Staging Systems and Inflammation Scores for Patients with Combined Hepatocellular Cholangiocarcinoma After Surgical Resection: a Retrospective Study. | J Gastrointest Surg | 2018 | https://conductscience.org/library/papers/29667093 | PubMed |
| 9 | 36836479 | Combining Preoperative Clinical and Imaging Characteristics to Predict MVI in Hepatitis B Virus-Related Combined Hepatocellular Carcinoma and Cholangiocarcinoma. | J Pers Med | 2023 | https://conductscience.org/library/papers/36836479 | PubMed |
| 10 | 35976399 | Histopathological components correlated with MRI features and prognosis in combined hepatocellular carcinoma-cholangiocarcinoma. | Eur Radiol | 2022 | https://conductscience.org/library/papers/35976399 | PubMed |
| 11 | 18284443 | Management of combined hepatocellular and cholangiocarcinoma. | Int J Clin Pract | 2008 | https://conductscience.org/library/papers/18284443 | PubMed |
| 12 | 38319170 | What a Radiologist Needs to Know About Radiomics, Standardization, and Reproducibility. | Radiology | 2024 | https://conductscience.org/library/papers/38319170 | PubMed |
| 13 | 39759152 | Clinicopathologic and ultrasonographic features of combined hepatocellular-cholangiocarcinoma and its correlation with microvascular invasion: a predictive role of contrast-enhanced ultrasound. | Front Oncol | 2024 | https://conductscience.org/library/papers/39759152 | PubMed |
| 14 | 26917546 | Combined hepatocellular carcinoma and cholangiocarcinoma (biphenotypic) tumors: clinical characteristics, imaging features of contrast-enhanced ultrasound and computed tomography. | BMC Cancer | 2016 | https://conductscience.org/library/papers/26917546 | PubMed |
| 15 | 35397928 | Prediction of Microvascular Invasion in Combined Hepatocellular-Cholangiocarcinoma Based on Pre-operative Clinical Data and Contrast-Enhanced Ultrasound Characteristics. | Ultrasound Med Biol | 2022 | https://conductscience.org/library/papers/35397928 | PubMed |
| 16 | 39732135 | An MRI-Based Radiomics Model for Preoperative Prediction of Microvascular Invasion and Outcome in Intrahepatic Cholangiocarcinoma. | Eur J Radiol | 2025 | https://conductscience.org/library/papers/39732135 | PubMed |
| 17 | 35392229 | Preoperative Prediction of Microvascular Invasion Risk Grades in Hepatocellular Carcinoma Based on Tumor and Peritumor Dual-Region Radiomics Signatures. | Front Oncol | 2022 | https://conductscience.org/library/papers/35392229 | PubMed |
| 18 | 36966771 | A nomogram for preoperative prediction of microvascular invasion in ruptured hepatocellular carcinoma. | Eur J Gastroenterol Hepatol | 2023 | https://conductscience.org/library/papers/36966771 | PubMed |
| 19 | 30689032 | Preoperative prediction of microvascular invasion in hepatocellular cancer: a radiomics model using Gd-EOB-DTPA-enhanced MRI. | Eur Radiol | 2019 | https://conductscience.org/library/papers/30689032 | PubMed |
| 20 | 33837585 | Comparing the clinicopathological characteristics of combined hepatocellular-cholangiocarcinoma with those of other primary liver cancers by use of the updated World Health Organization classification. | Histopathology | 2021 | https://conductscience.org/library/papers/33837585 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42226136
GET https://conductscience.org/api/papers/v1/42226136/references?page=2